Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prefrontal Cortex | 22 | 2022 | 640 | 3.250 |
Why?
|
| Synapses | 8 | 2019 | 222 | 2.010 |
Why?
|
| Glutamic Acid | 7 | 2019 | 332 | 1.790 |
Why?
|
| Methamphetamine | 4 | 2022 | 132 | 1.500 |
Why?
|
| Pyramidal Cells | 13 | 2022 | 79 | 1.330 |
Why?
|
| Synaptic Transmission | 7 | 2022 | 236 | 1.320 |
Why?
|
| Cognition Disorders | 2 | 2022 | 342 | 1.100 |
Why?
|
| Neurons | 8 | 2013 | 881 | 1.100 |
Why?
|
| Carrier Proteins | 4 | 2013 | 597 | 1.050 |
Why?
|
| Cocaine | 6 | 2023 | 555 | 1.010 |
Why?
|
| Cerebral Cortex | 4 | 2017 | 415 | 1.000 |
Why?
|
| Dopamine | 9 | 2022 | 474 | 0.930 |
Why?
|
| Dopamine Antagonists | 5 | 2019 | 65 | 0.900 |
Why?
|
| Dysbindin | 5 | 2016 | 9 | 0.890 |
Why?
|
| Excitatory Postsynaptic Potentials | 9 | 2017 | 87 | 0.880 |
Why?
|
| Action Potentials | 7 | 2010 | 223 | 0.850 |
Why?
|
| GABA Agents | 1 | 2022 | 18 | 0.830 |
Why?
|
| Central Nervous System Stimulants | 3 | 2019 | 221 | 0.810 |
Why?
|
| Evoked Potentials | 2 | 2019 | 61 | 0.760 |
Why?
|
| Rats, Sprague-Dawley | 15 | 2019 | 2083 | 0.690 |
Why?
|
| Optogenetics | 1 | 2019 | 20 | 0.690 |
Why?
|
| Cognition | 2 | 2022 | 513 | 0.680 |
Why?
|
| Animals | 30 | 2023 | 20881 | 0.640 |
Why?
|
| Rats | 19 | 2022 | 5300 | 0.620 |
Why?
|
| Spatial Behavior | 1 | 2017 | 18 | 0.610 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2019 | 266 | 0.600 |
Why?
|
| Conditioning, Classical | 1 | 2017 | 57 | 0.590 |
Why?
|
| Sex Characteristics | 1 | 2019 | 295 | 0.560 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2016 | 24 | 0.550 |
Why?
|
| Thalamus | 3 | 2003 | 82 | 0.530 |
Why?
|
| Membrane Potentials | 7 | 2009 | 200 | 0.500 |
Why?
|
| Receptors, Dopamine D1 | 4 | 2022 | 87 | 0.480 |
Why?
|
| Cocaine-Related Disorders | 2 | 2017 | 504 | 0.480 |
Why?
|
| Long-Term Potentiation | 2 | 2013 | 53 | 0.460 |
Why?
|
| Patch-Clamp Techniques | 7 | 2017 | 204 | 0.450 |
Why?
|
| Neural Inhibition | 3 | 2010 | 80 | 0.450 |
Why?
|
| Receptors, Dopamine D2 | 3 | 2010 | 109 | 0.440 |
Why?
|
| Electric Stimulation | 7 | 2013 | 218 | 0.420 |
Why?
|
| Immunosuppressive Agents | 1 | 2016 | 514 | 0.420 |
Why?
|
| Memory, Short-Term | 2 | 2010 | 79 | 0.420 |
Why?
|
| Fear | 1 | 2013 | 239 | 0.410 |
Why?
|
| Mutation | 2 | 2016 | 1213 | 0.390 |
Why?
|
| Dopamine Uptake Inhibitors | 2 | 2017 | 152 | 0.390 |
Why?
|
| In Vitro Techniques | 6 | 2013 | 765 | 0.380 |
Why?
|
| Interneurons | 3 | 2022 | 70 | 0.380 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2010 | 12 | 0.370 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2010 | 25 | 0.360 |
Why?
|
| Adrenergic alpha-Agonists | 2 | 2007 | 57 | 0.360 |
Why?
|
| Male | 24 | 2019 | 37321 | 0.360 |
Why?
|
| Receptors, Dopamine | 2 | 2006 | 119 | 0.350 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 2 | 2007 | 17 | 0.340 |
Why?
|
| Dystrophin-Associated Proteins | 4 | 2013 | 7 | 0.340 |
Why?
|
| Ventral Tegmental Area | 3 | 2006 | 74 | 0.320 |
Why?
|
| Self Administration | 5 | 2023 | 419 | 0.320 |
Why?
|
| Tissue Culture Techniques | 2 | 2019 | 62 | 0.310 |
Why?
|
| Substance Withdrawal Syndrome | 3 | 2010 | 435 | 0.310 |
Why?
|
| Mice | 8 | 2023 | 8474 | 0.310 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 1 | 2007 | 11 | 0.300 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2007 | 11 | 0.300 |
Why?
|
| Clonidine | 1 | 2007 | 66 | 0.300 |
Why?
|
| Potassium Channels | 1 | 2007 | 55 | 0.290 |
Why?
|
| Limbic System | 2 | 2003 | 106 | 0.260 |
Why?
|
| Mice, Inbred C57BL | 5 | 2016 | 2791 | 0.250 |
Why?
|
| Methylphenidate | 1 | 2006 | 97 | 0.250 |
Why?
|
| Mice, Transgenic | 3 | 2023 | 1033 | 0.250 |
Why?
|
| Synaptosomes | 2 | 2016 | 57 | 0.240 |
Why?
|
| Biogenic Monoamines | 1 | 2003 | 18 | 0.230 |
Why?
|
| Glutamates | 1 | 2003 | 41 | 0.230 |
Why?
|
| Electrophysiology | 5 | 2006 | 160 | 0.230 |
Why?
|
| Biophysics | 2 | 2013 | 41 | 0.220 |
Why?
|
| Heroin | 1 | 2023 | 49 | 0.210 |
Why?
|
| Globus Pallidus | 2 | 2001 | 64 | 0.200 |
Why?
|
| Mice, Inbred DBA | 2 | 2013 | 120 | 0.200 |
Why?
|
| Calcium | 2 | 2016 | 929 | 0.180 |
Why?
|
| Fourier Analysis | 1 | 2019 | 31 | 0.170 |
Why?
|
| Synaptic Potentials | 1 | 2019 | 8 | 0.170 |
Why?
|
| Antipsychotic Agents | 2 | 1998 | 247 | 0.160 |
Why?
|
| Cluster Analysis | 1 | 2019 | 219 | 0.160 |
Why?
|
| Mice, Knockout | 3 | 2013 | 1692 | 0.160 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 1293 | 0.160 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2019 | 92 | 0.150 |
Why?
|
| Excitatory Amino Acid Antagonists | 5 | 2009 | 128 | 0.150 |
Why?
|
| Dopamine Agonists | 3 | 2006 | 68 | 0.150 |
Why?
|
| Signal Transduction | 2 | 2005 | 2689 | 0.140 |
Why?
|
| Neural Pathways | 3 | 2009 | 324 | 0.130 |
Why?
|
| Social Behavior | 1 | 2016 | 164 | 0.130 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2016 | 124 | 0.130 |
Why?
|
| Neuronal Plasticity | 2 | 2009 | 274 | 0.120 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 507 | 0.120 |
Why?
|
| Memory | 1 | 2016 | 214 | 0.120 |
Why?
|
| Animals, Newborn | 2 | 2013 | 396 | 0.120 |
Why?
|
| Freezing Reaction, Cataleptic | 1 | 2013 | 10 | 0.120 |
Why?
|
| Excitatory Amino Acid Agents | 1 | 2013 | 20 | 0.110 |
Why?
|
| Algorithms | 1 | 2019 | 1196 | 0.110 |
Why?
|
| Bicuculline | 2 | 2005 | 17 | 0.110 |
Why?
|
| GABA Antagonists | 2 | 2005 | 22 | 0.110 |
Why?
|
| Potassium Chloride | 1 | 2013 | 45 | 0.110 |
Why?
|
| Synaptic Vesicles | 1 | 2013 | 18 | 0.110 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2013 | 20 | 0.110 |
Why?
|
| Pyridinium Compounds | 1 | 2013 | 40 | 0.110 |
Why?
|
| Calcium Channels | 1 | 2013 | 59 | 0.110 |
Why?
|
| Benzazepines | 2 | 2005 | 104 | 0.100 |
Why?
|
| Probability | 1 | 2013 | 245 | 0.100 |
Why?
|
| Analysis of Variance | 1 | 2013 | 1040 | 0.090 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 2550 | 0.090 |
Why?
|
| Physical Stimulation | 1 | 2010 | 67 | 0.090 |
Why?
|
| Hippocampus | 1 | 2013 | 471 | 0.090 |
Why?
|
| 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 2 | 2001 | 15 | 0.090 |
Why?
|
| Nucleus Accumbens | 3 | 2023 | 417 | 0.080 |
Why?
|
| Presynaptic Terminals | 1 | 2009 | 34 | 0.080 |
Why?
|
| Space Perception | 1 | 2009 | 44 | 0.080 |
Why?
|
| Attention | 1 | 2010 | 225 | 0.080 |
Why?
|
| Memory Disorders | 1 | 2009 | 111 | 0.080 |
Why?
|
| Haloperidol | 2 | 1998 | 95 | 0.080 |
Why?
|
| Free Radical Scavengers | 1 | 2009 | 112 | 0.080 |
Why?
|
| Cesium | 1 | 2007 | 7 | 0.080 |
Why?
|
| Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 1 | 2007 | 7 | 0.080 |
Why?
|
| Behavior, Animal | 2 | 2009 | 470 | 0.070 |
Why?
|
| Adenylyl Cyclases | 1 | 2007 | 94 | 0.070 |
Why?
|
| Type C Phospholipases | 1 | 2007 | 67 | 0.070 |
Why?
|
| Neuropsychological Tests | 1 | 2009 | 517 | 0.070 |
Why?
|
| Behavior, Addictive | 1 | 2010 | 317 | 0.070 |
Why?
|
| Mesencephalon | 1 | 2006 | 41 | 0.070 |
Why?
|
| Excitatory Amino Acid Agonists | 3 | 2006 | 59 | 0.070 |
Why?
|
| Neurotransmitter Agents | 1 | 2006 | 102 | 0.070 |
Why?
|
| Protein Kinase C | 1 | 2007 | 270 | 0.070 |
Why?
|
| Pyrimidines | 1 | 2007 | 178 | 0.070 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2006 | 32 | 0.070 |
Why?
|
| Catecholamines | 1 | 2006 | 73 | 0.070 |
Why?
|
| Methylazoxymethanol Acetate | 1 | 2005 | 1 | 0.070 |
Why?
|
| Acetylcysteine | 1 | 2009 | 296 | 0.060 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2005 | 32 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2006 | 1745 | 0.060 |
Why?
|
| Medial Forebrain Bundle | 1 | 2005 | 3 | 0.060 |
Why?
|
| Sulpiride | 1 | 2005 | 20 | 0.060 |
Why?
|
| Tetrodotoxin | 1 | 2005 | 26 | 0.060 |
Why?
|
| Oxidopamine | 1 | 2005 | 42 | 0.060 |
Why?
|
| Norepinephrine | 1 | 2006 | 276 | 0.060 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2005 | 84 | 0.060 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2005 | 71 | 0.060 |
Why?
|
| Drug-Seeking Behavior | 2 | 2023 | 213 | 0.060 |
Why?
|
| Electrochemistry | 1 | 2005 | 70 | 0.060 |
Why?
|
| Learning | 1 | 2006 | 186 | 0.060 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2005 | 154 | 0.060 |
Why?
|
| Nerve Net | 1 | 2006 | 181 | 0.060 |
Why?
|
| Coculture Techniques | 1 | 2003 | 147 | 0.060 |
Why?
|
| Organ Culture Techniques | 1 | 2003 | 122 | 0.060 |
Why?
|
| Motor Activity | 1 | 2006 | 621 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 1174 | 0.050 |
Why?
|
| Time Factors | 2 | 2007 | 4655 | 0.050 |
Why?
|
| Excitatory Amino Acids | 1 | 2001 | 8 | 0.050 |
Why?
|
| Subthalamic Nucleus | 1 | 2001 | 16 | 0.050 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 163 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2002 | 567 | 0.050 |
Why?
|
| Female | 3 | 2019 | 38074 | 0.040 |
Why?
|
| Piperazines | 1 | 2001 | 206 | 0.040 |
Why?
|
| Quinpirole | 1 | 1998 | 26 | 0.040 |
Why?
|
| Cell Size | 1 | 1998 | 76 | 0.040 |
Why?
|
| Ibotenic Acid | 1 | 1998 | 9 | 0.040 |
Why?
|
| Clozapine | 1 | 1998 | 46 | 0.040 |
Why?
|
| Extinction, Psychological | 1 | 2016 | 240 | 0.030 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2006 | 208 | 0.030 |
Why?
|
| Receptors, AMPA | 1 | 2010 | 99 | 0.020 |
Why?
|
| Rats, Long-Evans | 1 | 2010 | 203 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2010 | 447 | 0.020 |
Why?
|
| Receptor, Metabotropic Glutamate 5 | 1 | 2009 | 51 | 0.020 |
Why?
|
| Long-Term Synaptic Depression | 1 | 2009 | 32 | 0.020 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2009 | 75 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2009 | 291 | 0.020 |
Why?
|
| Neural Conduction | 1 | 2006 | 24 | 0.020 |
Why?
|
| Pyridines | 1 | 2009 | 261 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2005 | 104 | 0.020 |
Why?
|
| Reward | 1 | 2006 | 201 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2005 | 289 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2004 | 93 | 0.010 |
Why?
|
| Iontophoresis | 1 | 2001 | 7 | 0.010 |
Why?
|
| Microelectrodes | 1 | 2001 | 16 | 0.010 |
Why?
|
| Electrodes, Implanted | 1 | 2001 | 98 | 0.010 |
Why?
|
| Reaction Time | 1 | 2001 | 170 | 0.010 |
Why?
|
| Pregnancy | 1 | 2005 | 2334 | 0.010 |
Why?
|
| Humans | 1 | 2006 | 68618 | 0.000 |
Why?
|